Addressing Gender Related Issues and Bias in the Prevention and Treatment of Neurological Conditions

 

On 29 November 2022, the MEP Interest Group on Brain, Mind and Pain (BMP) hosted an in-person event in the European Parliament entitled “Addressing gender related issues and bias in the prevention and treatment of neurological conditions”. The event’s main objective was to discuss key barriers to prevention, diagnosis and treatment faced by women with neurological and chronic pain conditions, and understand what are the policy solutions that could improve women’s quality of life.

 

 

It was an honour and a privilege for Anna Dé, Policy Advisor at the Women’s Brain Project to join the panel debate. She focused her contribution on the impact on caregivers of people with neurological conditions. She stated that women are usually caregivers, excluding them from the workforce and making them vulnerable because they do not provide for themselves. Furthermore, if they have health issues, their needs are often not met. Anna Dé also emphasised the importance of understanding the sex differences in the prevention and risk factors of neurological conditions to educate women.

 

 

Anna Dé also outlined the vision and mission of the Women’s Brain Project, highlighting some of our activities, as we work to create a Research Institute for Sex and Gender Precision Medicine.

The meeting report can be accessed here.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

We are here to transform medicine and healthcare towards precision medicine. Right now, there is a critical need for your support. Donate today and help us continue to study Sex and Gender differences impacting brain and mental diseases.

Health begins with human beings, individuals – men and women are different when it comes to brain and mental disease frequency, severity, symptomatology, risk factors and even response to treatments. Thanks to the gifts from supporters like you the scientific community is starting to take note. We have shown the world that in diseases like Alzheimer’s for instance, disease progression is faster in women than men and women show different levels of biomarkers.

Our goal is to clearly identify such differences in diseases, diagnostic, and treatments, as well as novel technologies, and leverage them for better solutions. We ask for better clinical outcomes, better care, and innovative artificial intelligence (AI)-based solutions. Sex and gender differences are the first steps towards precision medicine, which acknowledges the specific needs of each patient. Our ultimate ambition is the realisation of the Research Institute for Sex and Gender Precision Medicine.